Clinical Trials Directory

Trials / Unknown

UnknownNCT01049256

The Cyclocapnic Method for Measurement of Chemosensitivity

Developing an Improved Measure of Chemosensitivity for the Study of Periodic Breathing in Heart Failure: the Cyclocapnic Method

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
Male
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

We aim to test our method for measuring chemosensitivity (the ventilatory response to a change in carbon dioxide), which uses sinusoidal carbon dioxide stimuli. Hypotheses: * Carbon dioxide sensitivity is dependent on the cycle time over which we administer the gas (frequency). * Chemoreflex gain decreases as deadspace increases.

Detailed description

We will apply a new method for the measurement of chemosensitivity (how sensitive a person is to changes in carbon dioxide), which is one of the principle determinants of whether people with heart failure develop abnormal breathing patterns We have shown in a pilot study that administering sinusoidal patterns of inspired carbon dioxide produces similar sinusoidal responses in ventilation. We aim to test our method for measuring chemosensitivity, which uses sinusoidal carbon dioxide stimuli (similar to those that drive the oscillations in ventilation found in periodic breathing). We aim to show that how the cycle time of carbon dioxide administered affects the resulting ventilatory oscillations and therefore that when measuring the chemoreflex clinically, it is important to deliver carbon dioxide stimuli that replicate the cycle time of oscillations in carbon dioxide seen in periodic breathing (typically approximately one minute).

Conditions

Interventions

TypeNameDescription
OTHERcarbon dioxidesinusoidal carbon dioxide administration

Timeline

Start date
2008-01-01
Primary completion
2010-04-01
Completion
2010-10-01
First posted
2010-01-14
Last updated
2010-01-14

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01049256. Inclusion in this directory is not an endorsement.